Status: Recruiting
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
The purpose of this clinical study is to assess the efficacy and safety of TachoSil compared to the widely known and used for \> 60 years local hemostatic product Surgicel Original as an adjunct to control mild to moderate soft tissue bleeding during surgery.
Participants needed: 116
Trial details
Phase: Phase 3Age: 1+Biological sex: AllType: InterventionalSponsor: Corza Medical GmbHUpdated: Jun 30, 2026Locations: 9
Eligibility criteria
Elective open abdominal, retroperitoneal, pelvic, or thoracic surgery. Elective... [+4]
Participants undergoing cardiovascular, hepatic, and laparoscopic and robotic su... [+9]